Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of the Immuno Suppressive Characteristics of Glioma Patients by an Integrated Radio-immunological Approach

NCT05267509 is registered in ClinicalTrials.gov with Istituto Oncologico Veneto IRCCS as lead sponsor.

NCT NCT05267509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05267509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of the Immuno Suppressive Characteristics of Glioma Patients by an Integrated Radio-immunological Approach
Lead sponsor
Istituto Oncologico Veneto IRCCS
Phase
Observational
Overall status
Active, not recruiting
Start date
February 23, 2022
Completion date
December 31, 2026
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, malignant